154 related articles for article (PubMed ID: 11526506)
1. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
[TBL] [Abstract][Full Text] [Related]
2. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
3. Regulatory mechanisms for abnormal expression of the human breast cancer specific gene 1 in breast cancer cells.
Lu A; Li Q; Liu J
Sci China C Life Sci; 2006 Aug; 49(4):403-8. PubMed ID: 16989287
[TBL] [Abstract][Full Text] [Related]
4. Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells.
Lu A; Zhang F; Gupta A; Liu J
J Biol Chem; 2002 Aug; 277(35):31364-72. PubMed ID: 12072430
[TBL] [Abstract][Full Text] [Related]
5. BCSG1 methylation status and BCSG1 expression in breast tissues derived from Chinese women with breast cancer.
Gu YM; Tan JX; Lu XW; Ding Y; Han X; Sun YJ
Oncology; 2008; 74(1-2):61-8. PubMed ID: 18544996
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
7. Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.
Liu H; Liu W; Wu Y; Zhou Y; Xue R; Luo C; Wang L; Zhao W; Jiang JD; Liu J
Cancer Res; 2005 Sep; 65(17):7635-43. PubMed ID: 16140929
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
Gupta A; Inaba S; Wong OK; Fang G; Liu J
Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
[TBL] [Abstract][Full Text] [Related]
9. Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing.
Ji H; Liu YE; Jia T; Wang M; Liu J; Xiao G; Joseph BK; Rosen C; Shi YE
Cancer Res; 1997 Feb; 57(4):759-64. PubMed ID: 9044857
[TBL] [Abstract][Full Text] [Related]
10. Genomic organization of the human KAI1 metastasis-suppressor gene.
Dong JT; Isaacs WB; Barrett JC; Isaacs JT
Genomics; 1997 Apr; 41(1):25-32. PubMed ID: 9126478
[TBL] [Abstract][Full Text] [Related]
11. Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.
Weng J; Ma W; Mitchell D; Zhang J; Liu M
J Cell Biochem; 2005 Dec; 96(5):1034-48. PubMed ID: 16149059
[TBL] [Abstract][Full Text] [Related]
12. CpG methylation within the 5' regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site.
Mancini DN; Rodenhiser DI; Ainsworth PJ; O'Malley FP; Singh SM; Xing W; Archer TK
Oncogene; 1998 Mar; 16(9):1161-9. PubMed ID: 9528858
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
Tanaka H; Shimada Y; Harada H; Shinoda M; Hatooka S; Imamura M; Ishizaki K
Cancer Res; 1998 Aug; 58(15):3429-34. PubMed ID: 9699676
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
Chen B; He L; Savell VH; Jenkins JJ; Parham DM
Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
[TBL] [Abstract][Full Text] [Related]
15. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
[TBL] [Abstract][Full Text] [Related]
16. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
[TBL] [Abstract][Full Text] [Related]
17. Methylation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells.
Arapshian A; Kuppumbatti YS; Mira-y-Lopez R
Oncogene; 2000 Aug; 19(35):4066-70. PubMed ID: 10962564
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers.
Dammann R; Yang G; Pfeifer GP
Cancer Res; 2001 Apr; 61(7):3105-9. PubMed ID: 11306494
[TBL] [Abstract][Full Text] [Related]
19. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
[TBL] [Abstract][Full Text] [Related]
20. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression.
Li B; Goyal J; Dhar S; Dimri G; Evron E; Sukumar S; Wazer DE; Band V
Cancer Res; 2001 Nov; 61(21):8014-21. PubMed ID: 11691827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
